UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033134
Receipt number R000037786
Scientific Title Confirmation of appropriate peripheral venous catheter placement by microbubble detection after normal saline administration using ultrasonography in pediatric patients: a randomized controlled trial
Date of disclosure of the study information 2018/06/25
Last modified on 2020/01/22 13:58:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Confirmation of appropriate peripheral venous catheter placement by microbubble detection after normal saline administration using ultrasonography in pediatric patients: a randomized controlled trial

Acronym

Confirmation of appropriate peripheral venous catheter placement by microbubble detection after normal saline administration using ultrasonography in pediatric patients: a randomized controlled trial

Scientific Title

Confirmation of appropriate peripheral venous catheter placement by microbubble detection after normal saline administration using ultrasonography in pediatric patients: a randomized controlled trial

Scientific Title:Acronym

Confirmation of appropriate peripheral venous catheter placement by microbubble detection after normal saline administration using ultrasonography in pediatric patients: a randomized controlled trial

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In pediatric intensive care unit, we randomly allocated patients in two groups. In ultrasound group, we perform microbubble test (MBT) as follows. We visualize patients' right atrium by cardiac ultrasonography (subcostal or apical four chamber view) and inject normal saline thorough peripherally venous catheters, which are already or newly inserted. We investigate whether microbubble is confirmed in right atrium using ultrasonography. In control group, we perform smooth injection test (SIT) as follows. We inject normal saline thorough peripherally venous catheters, and investigate whether injection is smoothly performed.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate which both tests are positive in case peripheral venous catheter was appropriately positioned intravenous.

Key secondary outcomes

The rate which both tests are negative in case peripheral venous catheter was positioned extravenous.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

In ultrasound group, we perform microbubble test (MBT) as follows. We visualize patients' right atrium by cardiac ultrasonography (subcostal or apical four chamber view) and inject normal saline thorough peripherally venous catheters, which are already or newly inserted. We investigate whether microbubble is confirmed in right atrium using ultrasonography.

Interventions/Control_2

In control group, we perform smooth injection test (SIT) as follows. We inject normal saline thorough peripherally venous catheters, and investigate whether injection is smoothly performed.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Pediatric patients whose body weights are under 15kg, admit to PICU of Osaka Women's and Children's hospital, and peripheral venous catheter were newly or already inserted.

Key exclusion criteria

Patients whose parents do not agree with this study.
Vasoactive agents are continuously administered through the peripheral venous catheter.
Appropriate four chamber view cannot be obtained.
Volume injection is restricted.
Hemodynamic status is unstable.
Patients who underwent Glenn operation or Fontan operation.
Anatomical abnormality of Vena cava.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Jun
Middle name
Last name Takeshita

Organization

Osaka Women's and Children's Hospital

Division name

Department of Intensive Care Medicine

Zip code

5941101

Address

840 Murodo-cho, Izumi, Osaka 594-1101

TEL

0725-56-1220

Email

t-k-s-t@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Jun
Middle name
Last name Takeshita

Organization

Osaka Women's and Children's Hospital

Division name

Department of Intensive Care Medicine

Zip code

5941101

Address

840 Murodo-cho, Izumi, Osaka 594-1101

TEL

0725-56-1220

Homepage URL


Email

t-k-s-t@koto.kpu-m.ac.jp


Sponsor or person

Institute

Osaka Women's and Children's Hospital, Department of Intensive Care Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Women's and Children's Hospital

Address

840 Murodo-cho, Izumi, Osaka

Tel

0725561220

Email

t-k-s-t@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

300

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 06 Month 22 Day

Date of IRB

2018 Year 06 Month 22 Day

Anticipated trial start date

2018 Year 06 Month 25 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 06 Month 25 Day

Last modified on

2020 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037786


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name